Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with Type 1 (insulin-dependent) diabetes mellitus

Summary

Serum levels of insulin-like growth factor I are reduced in patients with Type 1 (insulin-dependent) diabetes mellitus. To evaluate the role of the hepatic growth hormone receptor in the decreased serum concentrations of insulin-like growth factor I, serum levels of the high affinity growth hormone-binding protein, which is qualitatively and quantitatively related to the hepatic growth hormone receptor, and of insulin-like growth factor I were measured in 70 children and adolescents with Type 1 diabetes and 105 healthy control children. Analysis of variance revealed a significant negative effect of Type 1 diabetes on serum levels of the growth hormone-binding protein and of insulin-like growth factor I. In the diabetic patients, serum levels of the growth hormone-binding protein were positively related to body mass index and to insulin dose per kg body weight, and were not influenced by pubertal stage, gender, or plasma levels of haemoglobin A1c. Serum levels of insulin-like growth factor I increased during early puberty reaching peak levels at midpuberty and decreasing thereafter. No relationship was found between serum levels of growth hormone-binding protein and of insulin-like growth factor I. Our data suggest that decreased liver somatogenic receptor levels, as reflected by the concentrations of circulating growth hormone-binding protein, play a minor role in the suppressed concentrations of circulating insulin-like growth factor I. Post-growth hormone receptor defects or changes in the insulin-like growth factor binding proteins probably contribute more to the lower serum levels of insulin-like growth factor I.

References

  1. 1.

    Hayford JT, Danney MM, Hendrix JA, Thompson RG (1980) Integrated concentration of growth hormone in juvenile-onset diabetes. Diabetes 29: 391–398

  2. 2.

    Horner JM, Kemp SF, Hintz RL (1981) Growth hormone and somatomedin in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 53: 1148–1153

  3. 3.

    Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP (1990) Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab 71: 1356–1362

  4. 4.

    Blethen SL, Sargeant DT, Whitlow MG, Santiago JV (1981) Effect of pubertal stage and recent blood glucose control on plasma somatomedin C in children with insulin-dependent diabetes mellitus. Diabetes 30: 868–872

  5. 5.

    Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press CM, Tamborlane WV (1984) Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes. Diabetes 33: 1175–1179

  6. 6.

    Rogers DG, Sherman LD, Gabbay KH (1991) Effect of puberty on insulin like growth factor I and HbA1 in type I diabetes. Diabetes Care 14: 1031–1035

  7. 7.

    Baxter RC, Turtle JR (1978) Regulation of hepatic growth hormone receptors by insulin. Biochem Biophys Res Commun 84: 350–357

  8. 8.

    Baxter RC, Bryson JM, Turtle JR (1980) Somatogenic receptors of rat liver: regulation by insulin. Endocrinology 107: 1176–1181

  9. 9.

    Maes M, Underwood LE, Ketelslegers JM (1986) Low serum somatomedin-C in insulin-dependent diabetes: evidence for a post-receptor mechanism. Endocrinology 118: 377–382

  10. 10.

    Bornfeldt KE, Arnqvist HJ, Enberg B, Mathews LS, Norstedt G (1989) Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. J Endocrinol 122: 651–656

  11. 11.

    Ymer SI, Herington AC (1985) Evidence for the specific binding of growth hormone to a receptor-like protein in rabbit serum. Mol Cell Endocrinol 41: 153–161

  12. 12.

    Massa G, Mulumba N, Ketelslegers J-M, Maes M (1990) Initial characterization and sexual dimorphism of serum growth hormone-binding protein in adult rats. Endocrinology 126: 1976–1980

  13. 13.

    Baumann G, Stolar MW, Amburn K, Barsano CP, DeVries BC (1986) A specific growth hormone-binding protein in human plasma: initial characterization. J Clin Endocrinol Metab 62: 134–141

  14. 14.

    Herington AC, Ymer S, Stevenson J (1986) Identification and characterization of specific binding proteins for growth hormone in normal human sera. J Clin Invest 77: 1817–1823

  15. 15.

    Leung DW, Spencer SA, Cachianes G et al. (1987) Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330: 537–543

  16. 16.

    Daughaday WH, Trivedi B, Andrews BA (1987) The ontogeny of serum GH binding protein in man: a possible indicator of hepatic GH receptor development. J Clin Endocrinol Metab 65: 1072–1074

  17. 17.

    Tanner JM (1962) Growth at adolescence. 2nd edn. Blackwell Scientific Publishers, Oxford

  18. 18.

    Roede MJ, Van Wieringen JC (1985) Growth diagrams 1980 Netherlands third nation-wide survey. Tijdschr Soc Gezondheidsz 63 [Suppl]: 1–34

  19. 19.

    Rolland-Cachera MF, Sempé M, Guilloud-Bataille M, Patois E, Péquignot-Guggenbuhl F, Fautrad V (1982) Adiposity indices in children. Am J Clin Nutr 36: 178–184

  20. 20.

    Massa G, de Zegher F, Vanderschueren-Lodeweyckx M (1992) Serum growth hormone-binding proteins in the human foetus and infant. Pediatr Res 32: 69–72

  21. 21.

    Verhaeghe J, Suiker AMH, Visser WJ, Van Herck E, Van Bree R, Bouillon R (1992) The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats. J Endocrinol 134: 485–492

  22. 22.

    Gustafson TL (1991) True epistat manual. Epistat Services, Richardson, Texas

  23. 23.

    Mauras N, Merimee T, Rogol AD (1991) Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: evidence for defective target organ responsiveness in the Mauriac syndrome. Metabolism 40: 1106–1111

  24. 24.

    Menon RK, Arslanian S, May B, Cutfield WS, Sperling MA (1992) Diminished growth hormone-binding protein in children with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 74: 934–938

  25. 25.

    Mercado M, Molitch ME, Baumann G (1992) Low plasma growth hormone binding protein in IDDM. Diabetes 41: 605–609

  26. 26.

    Mulumba N, Massa G, Ketelslegers J-M, Maes M (1991) Ontogeny and nutritional regulation of the serum growth hormone-binding protein in the rat. Acta Endocrinol (Copenh) 125: 409–415

  27. 27.

    Hochberg Z, Hertz P, Colin V et al. (1992) The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism 41: 106–112

  28. 28.

    Silbergeld A, Lazar L, Erster B, Keret R, Tepper R, Laron Z (1989) Serum growth hormone binding protein activity in healthy neonates, children and young adults: correlation with age, height and weight. Clin Endocrinol (Oxf) 31: 295–303

  29. 29.

    Holl R, Snehotta R, Siegler B, Scherbaum W, Heinze E (1991) Binding protein for human growth hormone: effects of age and weight. Horm Res 35: 190–197

  30. 30.

    Massa G, Bouillon R, Vanderschueren-Lodeweyckx M (1992) Serum levels of growth hormone-binding protein and insulin-like growth factor I during puberty. Clin Endocrinol 37: 175–180

  31. 31.

    Ambler GR, Breier BH, Surus A et al. (1992) The interrelationship between and the regulation of hepatic growth hormone receptors and circulating GH binding protein in the pig. Acta Endocrinol (Copenh) 126: 155–161

  32. 32.

    Arner P, Sjöberg S, Gjötterberg M, Skottner A (1989) Circulating insulin-like growth factor I in type 1 (insulin-dependent) diabetic patients with retinopathy. Diabetologia 32: 753–758

  33. 33.

    Batch JA, Baxter RC, Werther G (1991) Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab 73: 964–968

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Massa, G., Dooms, L., Bouillon, R. et al. Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36, 239–243 (1993). https://doi.org/10.1007/BF00399957

Download citation

Key words

  • Body mass index
  • growth hormone
  • growth hormone-binding protein
  • growth hormone receptor
  • insulin-like growth factor
  • puberty